Macrogen, Inc. (KOSDAQ:038290)
16,520
+70 (0.43%)
Mar 12, 2026, 2:14 PM KST
Macrogen Market Cap
Macrogen has a market cap or net worth of 178.34 billion as of March 11, 2026. Its market cap has increased by 12.33% in one year.
Market Cap
178.34B
Enterprise Value
255.13B
Revenue
179.98B
Ranking
n/a
PE Ratio
n/a
Stock Price
16,520.00
Market Cap Chart
Since September 14, 2000, Macrogen's market cap has increased from 148.29B to 178.34B, an increase of 20.27%. That is a compound annual growth rate of 0.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 177.58B | -2.90% |
| Dec 30, 2025 | 182.89B | 11.21% |
| Dec 30, 2024 | 164.45B | -21.52% |
| Dec 28, 2023 | 209.56B | 8.16% |
| Dec 29, 2022 | 193.74B | -33.59% |
| Dec 30, 2021 | 291.72B | 9.42% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| JETEMA, | 324.87B |
| Bioneer | 317.47B |
| Helixmith | 272.60B |
| HLB Therapeutics | 257.75B |
| EASY BIO,Inc. | 231.24B |
| Genexine | 228.31B |
| Vaxcell-Bio Therapeutics | 190.71B |
| MedPacto | 175.83B |